Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regulus Therapeutics
(NQ:
RGLS
)
1.540
-0.050 (-3.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
190,830
Open
1.570
Bid (Size)
1.520 (1)
Ask (Size)
1.590 (12)
Prev. Close
1.590
Today's Range
1.490 - 1.583
52wk Range
1.080 - 3.790
Shares Outstanding
87,040,335
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q2 2024
August 09, 2024
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
June 25, 2024
Via
Benzinga
Performance
YTD
+17.56%
+17.56%
1 Month
-11.49%
-11.49%
3 Month
-25.96%
-25.96%
6 Month
-1.28%
-1.28%
1 Year
+14.07%
+14.07%
More News
Read More
What's Going On With Regulus Therapeutics Stock Monday?
June 24, 2024
Via
Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028
May 07, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
Analyst Expectations for Regulus Therapeutics's Future
September 21, 2023
Via
Benzinga
Expert Ratings for Regulus Therapeutics
June 28, 2023
Via
Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023
March 21, 2024
Via
InvestorPlace
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
March 13, 2024
Via
AB Newswire
Gold Down Over 1%; ClearOne Shares Spike Higher
March 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 12, 2024
Via
Benzinga
Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
March 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Regulus Therapeutics Inc. (NASDAQ: RGLS) is One of Tuesday Morning’s Most Active Stocks
March 12, 2024
Via
Investor Brand Network
Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February
March 12, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 12, 2024
Via
Benzinga
Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday?
March 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 12, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
September 21, 2023
Via
Benzinga
Regulus Therapeutics Releases Early Data From Of Investigational For Rare Type Of Kidney Disease
September 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 17, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.